PADELETTI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.598
EU - Europa 5.645
AS - Asia 1.224
OC - Oceania 89
AF - Africa 42
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.607
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.583
RU - Federazione Russa 1.836
PL - Polonia 1.542
IE - Irlanda 593
SE - Svezia 572
IT - Italia 396
HK - Hong Kong 378
SG - Singapore 376
UA - Ucraina 202
DE - Germania 196
CN - Cina 189
FI - Finlandia 152
IN - India 119
AU - Australia 89
GB - Regno Unito 87
JO - Giordania 56
TR - Turchia 43
CI - Costa d'Avorio 30
VN - Vietnam 30
FR - Francia 26
ID - Indonesia 18
CA - Canada 14
SC - Seychelles 10
CH - Svizzera 9
NL - Olanda 9
BE - Belgio 7
BR - Brasile 7
ES - Italia 6
JP - Giappone 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GE - Georgia 2
IR - Iran 2
KR - Corea 2
TJ - Tagikistan 2
UZ - Uzbekistan 2
EU - Europa 1
KG - Kirghizistan 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 16.607
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.045
Warsaw 1.542
Fairfield 1.201
Dublin 591
Ashburn 577
Chandler 557
Seattle 546
Woodbridge 543
Cambridge 524
Houston 450
Wilmington 410
Jacksonville 405
Singapore 311
Hong Kong 237
Ann Arbor 205
Princeton 173
Lawrence 146
Altamura 135
Mumbai 108
Boston 107
Boardman 100
Medford 86
Melbourne 83
Beijing 77
San Diego 74
Buffalo 58
Florence 42
Izmir 38
Kent 36
Norwalk 36
Falls Church 34
Moscow 31
Abidjan 30
New York 29
Dong Ket 28
Shanghai 24
Los Angeles 19
Jakarta 18
Milan 17
Hillsboro 14
Frankfurt Am Main 13
Andover 12
Phoenix 12
Rome 12
Auburn Hills 10
Helsinki 10
Redwood City 10
Yubileyny 10
Bern 9
Laurel 9
Brussels 7
Toronto 7
Barcelona 6
Castellarano 6
Duncan 6
San Lazzaro di Savena 6
Thiene 6
Verona 6
Bremen 5
London 5
Old Bridge 5
Paris 5
Pisa 5
Pune 5
Bastia umbra 4
Bologna 4
Guangzhou 4
Naples 4
Saint-Lambert 4
West Jordan 4
Genoa 3
Kilburn 3
Lecce 3
Preston 3
Saint Petersburg 3
Washington 3
Adelaide 2
Campi Bisenzio 2
Capergnanica 2
Catania 2
Cesena 2
Chiswick 2
Cosenza 2
Essen 2
Hounslow 2
Huizhou 2
Jesi 2
Leawood 2
Mogilëv 2
Munich 2
Orenburg 2
Poggibonsi 2
Prato 2
Prescot 2
Rožňava 2
San Mateo 2
Santana de Parnaíba 2
Scarperia e San Piero 2
Seoul 2
St Petersburg 2
Totale 11.964
Salva come PNG Salva come JPEG
Nome #
Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation. 279
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. 272
Short- and long-term cardiac events in patients with chest pain with or without known existing coronary disease presenting normal electrocardiogram. 272
Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations. 259
ATRIAL FIBRILLATION AND CANCER: EVIDENCE FOR AN EPIDEMIOLOGICAL LINK 258
Atrial Fibrillation After Cardiac Surgery: Incidence, Risk Factors, and Economic Burden 236
Aggressive approach and outcome in patients presenting atrial fibrillation and hypertension 231
Obstructive sleep apnea after myocardial infarction. 230
Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. 219
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 210
Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry). 202
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 181
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 159
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 142
Management of patients with acute atrial fibrillation in the ED 138
Effects of smoking in patients treated with cardiac resynchronization therapy 138
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 131
Cardiac resynchronization therapy improves functional status and cognition 130
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 128
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 127
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? 126
Left ventricular mass and progenitor cells in chronic heart failure patients 126
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 126
Electrophysiologic procedures and activation of the hemostatic system 125
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients 123
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 123
Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty 123
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 122
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 122
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 121
Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation 120
A contribution for validation of ECG criteria for interatrial conduction delay. 120
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 119
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 119
Cardiac effects of clomipramine treatment 118
Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. 118
Multicenter experience with implantable defibrillators subject to recall. 117
Enhanced cardiac norepinephrine release in patients with idiopathic ventricular tachycardia related to the occurrence of arrhythmias 116
Arterial stiffness and left ventricular performance in elderly patients with persistent atrial fibrillation 116
Thoracic electric impedance and its changes after multiple shocks for external cardioversion of atrial fibrillation. A role for acute inflammatory response? 116
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 116
Cardiac amyloidosis: the heart of the matter. 116
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 115
Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project) 115
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. 114
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 114
Rhythmic and haemodynamic determinants of long-term survival after radiofrequency ablation of atrial fibrillation in mitral valve surgery 114
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 113
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 113
Long-term Prognostic Value of Dysglycemia and Ischemic Vascular Disease Beyond Abnormal Troponin Levels in Patients Presenting Acute Atrial Fibrillation. 112
Evolution and prognostic significance of diastolic filling pattern in cardiac resynchronization therapy. 112
Dual-site left ventricular cardiac resynchronization therapy. 111
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation 110
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 110
Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy 108
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 108
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 107
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 106
La morte cardiaca improvvisa in Italia. Dimensioni, percezioni, politiche 105
Atrial fibrillation in athletes 105
Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSISLOG study. 104
Koch and the "ultimum moriens" theory - the last part to die of the heart 104
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 103
Bioavailability of digoxin-hydroquinone complex 102
Atrial standstill disease progression documented after 13 years follow-up 102
Sex-related differences in chronic heart failure 102
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 101
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: The MINERVA randomized multicentre international trial 101
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. 100
Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy. 100
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. 99
Determinants of thoracic electrical impedance in external electrical cardioversion of atrial fibrillation. 99
Rational bases for the therapy of supraventricular tachycardias and their management 97
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. 97
Pacemaker selection: time for a rethinking of complex pacing systems? 96
Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. 96
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements 96
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 96
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. 93
Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. 93
Age-related effects on mortality of the implantable cardioverter defibrillator. An analysis of the Italian clinical service project database 93
Activation of the coagulation system during electrophysiologic invasive study with and without ablation 92
Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. 92
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. 91
Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. 91
Cardiac amyloidosis: the heart of the matter. 91
Implantable cardioverter defibrillator in sport participation. 91
Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation. 90
Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. 90
Activation of hemostatic system during electrophysiological procedures 89
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 89
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 89
External cardioversion of atrial fibrillation causes an early improvement of cardiac performance: A longitudinal strain analysis study 88
Prognostic role of post infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein assessment after myocardial infarction to guide implantation of defibrillator (CAMI GUIDE) study 88
Digital technology for cardiac pacing. 87
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: peliminary data 87
Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. 86
The risk profile for obstructive sleep apnea does not affect the recurrence of atrial fibrillation. 86
Coherent averaging improves the evaluation of left ventricular dyssynchrony by conductance catheter. 86
Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study. 86
Totale 12.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.410 0 0 0 0 0 0 312 386 292 158 215 47
2020/20211.707 143 121 149 164 58 205 69 181 144 223 93 157
2021/20221.025 29 91 71 43 48 56 28 70 72 56 168 293
2022/20232.528 274 431 95 178 181 465 376 145 242 16 84 41
2023/2024836 57 105 176 53 59 109 32 159 3 17 45 21
2024/20255.112 227 712 437 1.058 1.888 711 79 0 0 0 0 0
Totale 16.707